This Workshop explores the interlinkages between trade and public health in a holistic manner. Its objective is to build capacity to analyse, undertake policy choices and foster coherent decision making.

Participants will be exposed to WTO disciplines related to public health, as well as to the work undertaken by WIPO and the WHO. The combination of round-table discussions, presentations by experts from different disciplines and case studies is designed to stimulate interaction and experience sharing. In particular, the workshop will cover key factors that influence innovation and access in the pharmaceutical sector, including: public health determinants; intellectual property rights; pricing and procurement policies; competition policy and rules; tariffs, quotas and licensing; and health services. A separate section will deal with regulatory issues, including the approval, quality control and effectiveness of medicines, the protection of clinical test data under the TRIPS Agreement and health-related measures in the TBT and SPS Committees. This will be complemented by a s

Notes/Key results
1. Government officials are implementing WTO Agreements and making full use of Members' rights

Trade Information
Project Number	TC17/9
Trade Category	Trade-Related Intellectual Property Rights
Dates	06/11/2017 - 10/11/2017
Reporting Agency	World Trade Organization (WTO)
Implementing Agencies / Countries	World Trade Organization (WTO)
Cooperating Agencies
Host Country	Switzerland
Invited Countries
Afghanistan; Albania; Algeria; Andorra; Angola; Antigua and Barbuda; Argentina; Armenia; Australia; Austria; Azerbaijan; Bahamas (The); Bahrain; Bangladesh; Barbados; Belarus; Belgium; Belize; Benin; Bhutan; Bolivia; Bosnia and Herzegovina; Botswana; Brazil; Brunei Darussalam; Bulgaria; Burkina Faso; Burundi; Cambodia; Cameroon; Canada; Cape Verde; Central African Rep.; Chad; Chile; China; Chinese Taipei; Colombia; Comoros; Congo; Congo, Democratic Republic of; Costa Rica; Côte d'Ivoire; Croatia; Cuba; Cyprus; Czech Republic; Denmark; Djibouti; Dominica; Dominican Republic; Ecuador; Egypt; El Salvador; Equatorial Guinea; Estonia; Eswatini; Ethiopia; European Union; Fiji; Finland; France; Gabon; Gambia (The); Georgia; Germany; Ghana; Greece; Grenada; Guatemala; Guinea; Guinea-Bissau; Guyana; Haiti; Honduras; Hong Kong, China; Hungary; Iceland; India; Indonesia; Iran, Islamic Republic of; Iraq; Ireland; Israel; Italy; Jamaica; Japan; Jordan; Kazakhstan; Kenya; Korea, Rep. of; Kuwait; Kyrgyz Republic; Lao People's Democratic Republic; Latvia; Lebanon; Lesotho; Liberia; Libya; Liechtenstein; Lithuania; Luxembourg; Macao, China; Madagascar; Malawi; Malaysia; Maldives; Mali; Malta; Mauritania; Mauritius; Mexico; Moldova; Mongolia; Montenegro; Morocco; Mozambique; Myanmar; Namibia; Nepal; Netherlands; New Zealand; Nicaragua; Niger; Nigeria; Norway; Oman; Pakistan; Panama; Papua New Guinea; Paraguay; Peru; Philippines; Poland; Portugal; Qatar; Romania; Russian Federation; Rwanda; Samoa; Sao Tome and Principe; Saudi Arabia; Senegal; Serbia; Seychelles; Sierra Leone; Singapore; Slovak Rep.; Slovenia; Solomon Islands; Somalia; South Africa; Spain; Sri Lanka; St. Kitts and Nevis; St. Lucia; St. Vincent and the Grenadines; Sudan; Suriname; Sweden; Switzerland; Syrian Arab Republic; Tajikistan; Tanzania, United Republic of; Thailand; The Former Yugoslav Republic of Macedonia; Timor-Leste; Togo; Tonga; Trinidad and Tobago; Tunisia; Turkey; Uganda; Ukraine; United Arab Emirates; United Kingdom; United States; Uruguay; Uzbekistan; Vanuatu; Venezuela, Bolivarian Repubic of; Viet Nam; Yemen; Zambia; Zimbabwe
E-mail contact / Web Address
trta.admin@wto.org